GT Medical Technologies Announces UNC Health as New GammaTile Center of Excellence in Cancer Care GT Medical Technologies designates UNC Health as a GammaTile Center of Excellence, recognizing its exceptional standards in brain tumor treatment.

GT Medical Technologies Announces UNC Health as New GammaTile Center of Excellence in Cancer Care #United_States #Tempe #GammaTile #GT_Medical #UNC_Health

GT Medical Technologies to Showcase Innovations at J.P. Morgan Healthcare Conference GT Medical Technologies, an innovative medical device company, will highlight breakthroughs in brain tumor treatment at the upcoming J.P. Morgan Healthcare Conference.

GT Medical Technologies to Showcase Innovations at J.P. Morgan Healthcare Conference #United_States #San_Francisco #GammaTile #GT_Medical #brain_tumors

Innovative GammaTile Treatment Shows Promising Results in Brain Tumor Control during Clinical Trials Recent clinical trial results reveal GammaTile's effectiveness in enhancing tumor control for operable brain metastases, leading to better patient outcomes compared to standard treatments.

Innovative GammaTile Treatment Shows Promising Results in Brain Tumor Control during Clinical Trials #United_States #Tempe #GammaTile #GT_Medical #brain_tumors

GT Medical Technologies Designates Rush University as GammaTile Center of Excellence for Brain Tumor Care GT Medical Technologies proudly announces Rush University Medical Center as the new GammaTile Center of Excellence, recognizing leadership in brain tumor treatment and patient education.

GT Medical Technologies Designates Rush University as GammaTile Center of Excellence for Brain Tumor Care #USA #Tempe #GammaTile #GT_Medical #Rush_University

GT Medical Technologies Designates UofL Health as a GammaTile® Center of Excellence GT Medical Technologies has announced UofL Health's designation as a GammaTile® Center of Excellence, highlighting the institution's expertise in brain tumor treatments.

GT Medical Technologies Designates UofL Health as a GammaTile® Center of Excellence #United_States #Louisville #GammaTile #GT_Medical #UofL_Health

GT Medical Technologies Secures $53 Million in Series D Financing to Enhance Brain Tumor Treatments GT Medical Technologies has successfully closed an oversubscribed $53 million Series D equity financing aimed at advancing treatments for operable brain tumors. The funds will support clinical trials and commercialization efforts.

GT Medical Technologies Secures $53 Million in Series D Financing to Enhance Brain Tumor Treatments #USA #Tempe #GammaTile #GT_Medical #Series_D

GT Medical Technologies Designates Mayfield Brain Spine as a Center of Excellence for GammaTile® Program GT Medical Technologies has named Mayfield Brain & Spine as the newest GammaTile® Center of Excellence, highlighting their excellence in brain tumor treatment and patient care.

GT Medical Technologies Designates Mayfield Brain Spine as a Center of Excellence for GammaTile® Program #United_States #Tempe #GammaTile #GT_Medical #Mayfield_Brain

GT Medical Technologies Appoints James Leech as New Chief Financial and Strategy Officer GT Medical Technologies has appointed James Leech as the Chief Financial and Strategy Officer, enhancing its mission to address the needs of brain tumor patients.

GT Medical Technologies Appoints James Leech as New Chief Financial and Strategy Officer #United_States #GammaTile #GT_Medical #Tempe,_Arizona #James_Leech

GT Medical Technologies Announces New GammaTile® Center of Excellence Recognition for Westchester Medical Center GT Medical Technologies has designated Westchester Medical Center as a GammaTile® Center of Excellence, acknowledging their innovative approach in brain tumor treatment.

GT Medical Technologies Announces New GammaTile® Center of Excellence Recognition for Westchester Medical Center #USA #Tempe #GammaTile #GT_Medical #Westchester_Med

GT Medical Technologies Names New GammaTile Center of Excellence in St. Louis GT Medical Technologies has designated SSM Health Saint Louis University Hospital as a new GammaTile Center of Excellence, emphasizing advancements in brain tumor treatment.

GT Medical Technologies Names New GammaTile Center of Excellence in St. Louis #USA #Saint_Louis #GammaTile #GT_Medical #SSM_Health

GT Medical Technologies Celebrates Allegheny Health Network as Newest GammaTile Center of Excellence GT Medical Technologies has designated Allegheny Health Network as a new GammaTile Center of Excellence, acknowledging superior brain tumor care through innovative treatments.

GT Medical Technologies Celebrates Allegheny Health Network as Newest GammaTile Center of Excellence #United_States #GT_Medical #Tempe,_Arizona #Allegheny_Health #GammaTile_Center

GT Medical Technologies Secures $37 Million to Propel GammaTile® Expansion for Brain Tumor Patients in the U.S. GT Medical Technologies has secured $37 million in a Series D financing round, aimed at advancing the GammaTile® treatment for brain tumors.

GT Medical Technologies Secures $37 Million to Propel GammaTile® Expansion for Brain Tumor Patients in the U.S. #United_States #Tempe #GammaTile #GT_Medical #brain_tumors